Variant report
Variant | esv1825777 |
---|---|
Chromosome Location | chr5:68832957-68849594 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:43)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:43 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:68834691-68834785 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr5:68834723-68834923 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr5:68833712-68833856 | Pancreas_OC | pancreas: | n/a | n/a |
4 | CTCF | chr5:68838421-68838427 | GM20000 | blood: | n/a | n/a |
5 | CTCF | chr5:68838439-68838481 | GM20000 | blood: | n/a | n/a |
6 | CTCF | chr5:68833712-68833842 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr5:68833702-68833774 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr5:68833553-68833648 | GM10266 | blood: | n/a | n/a |
9 | CTCF | chr5:68833676-68833858 | LNCaP | prostate: | n/a | n/a |
10 | FOSL2 | chr5:68834556-68834951 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr5:68840155-68840694 | HepG2 | liver: | n/a | n/a |
12 | FOXA1 | chr5:68842830-68843191 | HepG2 | liver: | n/a | chr5:68842988-68843000 |
13 | FOXA1 | chr5:68834450-68834935 | HepG2 | liver: | n/a | n/a |
14 | JUND | chr5:68834705-68834820 | HepG2 | liver: | n/a | n/a |
15 | JUND | chr5:68834583-68834856 | HepG2 | liver: | n/a | n/a |
16 | MYBL2 | chr5:68834548-68834980 | HepG2 | liver: | n/a | n/a |
17 | MYC | chr5:68833284-68833360 | MCF-7 | breast: | n/a | n/a |
18 | MYC | chr5:68840594-68840707 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr5:68840837-68840852 | A549 | lung: | n/a | n/a |
20 | POLR2A | chr5:68833123-68833425 | ProgFib | skin: | n/a | n/a |
21 | POLR2A | chr5:68834606-68834796 | HepG2 | liver: | n/a | n/a |
22 | POLR2A | chr5:68840766-68840832 | A549 | lung: | n/a | n/a |
23 | POLR2A | chr5:68840912-68840954 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr5:68835590-68835691 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | POLR2A | chr5:68844581-68844753 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | POLR2A | chr5:68840874-68840902 | MCF-7 | breast: | n/a | n/a |
27 | POLR2A | chr5:68838423-68838427 | MCF-7 | breast: | n/a | n/a |
28 | POLR2A | chr5:68840747-68840759 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr5:68835315-68835333 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr5:68847935-68848017 | MCF-7 | breast: | n/a | n/a |
31 | POLR2A | chr5:68838476-68838489 | MCF-7 | breast: | n/a | n/a |
32 | POLR2A | chr5:68834348-68834409 | MCF-7 | breast: | n/a | n/a |
33 | POLR2A | chr5:68835561-68835579 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | POLR2A | chr5:68847934-68847986 | A549 | lung: | n/a | n/a |
35 | POLR2A | chr5:68847053-68847135 | Gliobla | brain: | n/a | n/a |
36 | POLR2A | chr5:68835482-68835531 | MCF-7 | breast: | n/a | n/a |
37 | POLR2A | chr5:68833047-68833147 | MCF-7 | breast: | n/a | n/a |
38 | POLR2A | chr5:68835285-68835304 | MCF-7 | breast: | n/a | n/a |
39 | POLR2A | chr5:68844558-68844760 | H1-hESC | embryonic stem cell: | n/a | n/a |
40 | RXRA | chr5:68834571-68834922 | HepG2 | liver: | n/a | n/a |
41 | SP1 | chr5:68834522-68834969 | HepG2 | liver: | n/a | n/a |
42 | SP1 | chr5:68842931-68843164 | HepG2 | liver: | n/a | n/a |
43 | TCF12 | chr5:68834620-68834821 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238740 | TF binding region |
OCLN | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373134497 | chr5:68833279-68833280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560307108 | chr5:68833605-68833606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568971079 | chr5:68833606-68833607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531363581 | chr5:68833607-68833608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200271483 | chr5:68833837-68833838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185979339 | chr5:68833909-68833910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377593765 | chr5:68833951-68833952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370624234 | chr5:68834017-68834018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545843806 | chr5:68834155-68834156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563923583 | chr5:68834208-68834209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532072791 | chr5:68834219-68834220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550216840 | chr5:68834310-68834311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551063957 | chr5:68834670-68834671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568038210 | chr5:68834714-68834715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75758747 | chr5:68835256-68835257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111906095 | chr5:68835478-68835479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111963051 | chr5:68836458-68836459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2666583 | chr5:68838938-68838939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62371755 | chr5:68839366-68839367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568708094 | chr5:68840639-68840640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374647565 | chr5:68840793-68840794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377718385 | chr5:68840825-68840826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529478147 | chr5:68840860-68840861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547569464 | chr5:68840877-68840878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370970569 | chr5:68840886-68840887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144743806 | chr5:68840898-68840899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539541122 | chr5:68840909-68840910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557769604 | chr5:68840949-68840950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374290737 | chr5:68840951-68840952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569957677 | chr5:68840963-68840964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537407554 | chr5:68840977-68840978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556208975 | chr5:68840996-68840997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574644845 | chr5:68841050-68841051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542082960 | chr5:68841091-68841092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553989126 | chr5:68841159-68841160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200539187 | chr5:68841258-68841259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2666581 | chr5:68841325-68841326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2561167 | chr5:68841353-68841354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112435330 | chr5:68841374-68841375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572218624 | chr5:68842313-68842314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545907196 | chr5:68842314-68842315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571000746 | chr5:68842315-68842316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564168490 | chr5:68842354-68842355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531228553 | chr5:68842723-68842724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543369961 | chr5:68842788-68842789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562278457 | chr5:68842789-68842790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529521280 | chr5:68842797-68842798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374288539 | chr5:68842814-68842815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368868008 | chr5:68842829-68842830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190800304 | chr5:68842970-68842971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68824000-68855400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr5:68828200-68840800 | Weak transcription | Pancreas | Pancrea |
3 | chr5:68829600-68855400 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr5:68840800-68841000 | Enhancers | Pancreas | Pancrea |
5 | chr5:68840800-68841000 | Enhancers | HepG2 | liver |
6 | chr5:68841000-68841200 | Weak transcription | Pancreas | Pancrea |
7 | chr5:68841000-68855200 | Weak transcription | HepG2 | liver |
8 | chr5:68844400-68855400 | Weak transcription | Fetal Intestine Large | intestine |
9 | chr5:68845800-68855600 | Weak transcription | H9 Cell Line | embryonic stem cell |